| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/06/2008 | CN101234144A Dropping pills for treating toothache and preparation thereof |
| 08/06/2008 | CN101234143A Method for preparing plaster for treating lumbar sprain disease |
| 08/06/2008 | CN101234125A Method of preparing granulation physiotherapeutic salt |
| 08/06/2008 | CN101234124A Method of preparing crystallization physiotherapeutic salt |
| 08/06/2008 | CN101234090A Kukoline or its salts sustained-release microsphere and preparation thereof and sustained-release injection preparations |
| 08/06/2008 | CN101233885A Health tea |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408571C Andrographolide-trimaleate and its salt and their medicine composition |
| 08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/06/2008 | CN100408561C 2,3'-bipyridines derivatives as selective cox-2 inhibitors |
| 08/06/2008 | CN100408086C Health product for resisting inflammation, stopping pain and promoting rehabilitation of articular cartilage |
| 08/06/2008 | CN100408060C Externally applied medicinal wine for treating rheumatism |
| 08/06/2008 | CN100408049C Medicine for treating rheumatic arthritis and ankylosing spondylitis and its preparing process |
| 08/06/2008 | CN100408048C Capsule for treating rheumatism and rheumatoid diseases and scapulohumeral periarthritis and preparation method thereof |
| 08/05/2008 | US7408021 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407963 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 08/05/2008 | US7407952 substance P, integrin receptor antagonist; mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins; antiinflammatory agent; cell adhesion-mediated disease and central nervous system disorders |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407931 Administering an hematopoietic colony stimulating factors of sargramostim; Crohn's Disease |
| 08/05/2008 | US7407669 film delivers at least one oral care agent, such as antimicrobial agents and salivary stimulants |
| 08/05/2008 | CA2404152C Inhibition of cyclooxygenase-2 activity |
| 08/05/2008 | CA2388476C Bicyclic imidazo-5-yl-amine derivatives |
| 08/05/2008 | CA2332271C Selective cyclooxygenase-2 anti-inflammatory eye drops |
| 08/05/2008 | CA2268450C Neurotrophin antagonist compositions |
| 08/05/2008 | CA2137378C D-enzyme compositions and methods of their use |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090940A1 Pharmaceutical agent comprising dopamine d2-like receptor agonist as active ingredient and screening method |
| 07/31/2008 | WO2008090831A1 Enzyme composition and use thereof |
| 07/31/2008 | WO2008090717A1 Adam inhibitor |
| 07/31/2008 | WO2008090076A1 Oral pharmaceutical compositions in the form of stabilised aqueous solutions |
| 07/31/2008 | WO2008075978A3 An extract |
| 07/31/2008 | WO2008071948A3 Aminoalcohol derivatives and their therapeutic use |
| 07/31/2008 | WO2008068429A3 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 07/31/2008 | WO2008067234A3 Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome |
| 07/31/2008 | WO2008060626A9 Compounds for modulating trpv3 function |
| 07/31/2008 | WO2008036653A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 07/31/2008 | WO2008009664A3 Treatment of pain |
| 07/31/2008 | WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/31/2008 | US20080182994 Crystallization from solvent; removal of impurities |
| 07/31/2008 | US20080182975 Framework-Patched Immunoglobulins |
| 07/31/2008 | US20080182907 External pharmaceutical composition containing tramadol |
| 07/31/2008 | US20080182901 Crystalline acid of lipoxin A4 analogs and method of making |
| 07/31/2008 | US20080182897 Crystalline potassium salt of lipoxin A4 analogs |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182881 TNF-alpha production inhibitors |
| 07/31/2008 | US20080182879 e.g. 6-hydroxy-2-[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]chromone; tyrosine kinase inhibitors, anticarcinogenic and antiinflammatory agent; cerebral, genito-urinary tract, lymphatic system, stomach, laryngeal, pancreatic, breast or lung tumor; rheumatoid arthritis, psoriasis, contact dermatitis |
| 07/31/2008 | US20080182850 3-(heteroaryl)alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4 |
| 07/31/2008 | US20080182844 7-Substituted Aza-Indazoles, Compositions Containing Same, Production Method and Use Thereof |
| 07/31/2008 | US20080182841 Sustained release bioadhesive carrier such as polycarbophil; coronary antiarrhythmic; local anesthetic; calcium channel blocker; autocoid; antiprostaglandin; nonsteroidal antiinflammatory; cyclooxygenase, thromboxane or leukotriene inhibitor; infertility |
| 07/31/2008 | US20080182839 LFA1 related immune and/or inflammatory disorders; interactions with leukointegrins; such as fused nitrogen heterocyclic secondary amine derivatives |
| 07/31/2008 | US20080182837 New chemical compounds |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182801 Core 2 glcnac-t inhibitors |
| 07/31/2008 | US20080182787 Protein isolated from plants (Moringa) or synthesized by recombinant DNA technology; enzyme inhibitors; prevention and treatment of metabolic, cardiovascular, and inflammatory diseases |
| 07/31/2008 | US20080182778 Identification of an Evolutionarily Conserved Pathway Mediating Transrepression of Inflammatory Response Genes by Nuclear Receptors |
| 07/31/2008 | US20080182313 Polypeptide of 250-419 contiguous amino acids of SEQ ID NO:1, where tyrosine 216 is phosphorylated and the polypeptide will crystallize; biological activity consisting of binding a GSK3 inhibitor and kinase activity; antidiabetic agents; Alzeimer's disease; antiinflammation agents; biological screening |
| 07/31/2008 | US20080181928 stent; coating comprising a dry film comprising at least one lipid bilayer and at least one pharmaceutically effective agent; Upon exposure to an aqueous fluid, liposomes are released |
| 07/31/2008 | US20080181920 Salicylic acid, glycolic acid, and titanium-/zinc- oxide pigments |
| 07/31/2008 | US20080181897 Which specifically bind to or interact with human G-CSF receptor and dimerize the receptor or activate phosphorylation of kinases associated with the receptor to stimulate cell proliferation and differentiation |
| 07/31/2008 | US20080181854 antiinflammatory ascomycin derivative pimecrolimus in the form of a foam; inflammatory and hyperproliferative skin diseases and of cutaneous manifestations of immunologically-mediated diseases |
| 07/31/2008 | US20080179246 Method of obtaining a natural hydroxytyrosol-rich concentrate from olive tree residues and subproducts using clean technologies |
| 07/31/2008 | CA2676353A1 Production of rosmarinic acid from spearmint and uses thereof |
| 07/30/2008 | EP1950301A2 Antibody for use in Therapy |
| 07/30/2008 | EP1950300A2 Antibody variants with higher binding affinity compared to parent antibodies |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950219A1 Novel dihydropseudoerythromycin derivatives |
| 07/30/2008 | EP1950206A1 Benzoxazocines and their use as monoamine-reuptake inhibitors |
| 07/30/2008 | EP1950205A1 Method for stabilization of isoxazole compound |
| 07/30/2008 | EP1950200A1 [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949901A2 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 07/30/2008 | EP1948691A1 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH a4ß7INTEGRIN |
| 07/30/2008 | EP1948657A1 Azaindazoles useful as inhibitors of kinases |
| 07/30/2008 | EP1948638A1 Compounds for the treatment of inflammatory disorders |
| 07/30/2008 | EP1948636A2 Compounds and compositions as lxr modulators |
| 07/30/2008 | EP1948623A2 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 07/30/2008 | EP1948616A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 07/30/2008 | EP1948192A2 Therapeutic uses of steroidal compounds |
| 07/30/2008 | EP1948182A1 Method for treating neuronal and non-neuronal pain |
| 07/30/2008 | EP1948174A2 Fluridone as an anti-inflammatory agent |
| 07/30/2008 | EP1948168A2 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 07/30/2008 | EP1948167A1 Compositions of phosphodiesterase type iv inhibitors |
| 07/30/2008 | EP1948145A2 Protection of oxidizable agents |
| 07/30/2008 | EP1817079B1 Treatment of inflammation |
| 07/30/2008 | EP1747204B1 Tri-substituted ureas as cytokine inhibitors |
| 07/30/2008 | EP1633729B1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1478394B1 Stabilized TNFR-Fc composition comprising arginine |
| 07/30/2008 | EP1418881B1 Synergistic antimicrobial ophthalmic preparations containing chlorite and hydrogen peroxide |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | EP1025124B1 Low-toxicity human interferon-alpha analogues |
| 07/30/2008 | CN101233154A Stable and soluble antibodies inhibiting TNF alpha |
| 07/30/2008 | CN101233132A Compounds for modulating TRPV3 function |
| 07/30/2008 | CN101230083A Novel glycyrrhetinic acid derivatives and preparation method thereof |
| 07/30/2008 | CN101230024A Novel water-soluble azulene derivatives and preparation method thereof |